Dynamic Technology Lab Private Ltd Makes New $1.94 Million Investment in Amdocs Limited $DOX

Dynamic Technology Lab Private Ltd purchased a new stake in Amdocs Limited (NASDAQ:DOX) during the second quarter, HoldingsChannel.com reports. The fund purchased 21,299 shares of the technology company’s stock, valued at approximately $1,943,000.

Other institutional investors and hedge funds have also modified their holdings of the company. IFP Advisors Inc grew its stake in Amdocs by 11.0% in the 1st quarter. IFP Advisors Inc now owns 2,294 shares of the technology company’s stock valued at $215,000 after buying an additional 228 shares during the last quarter. Lindbrook Capital LLC grew its position in shares of Amdocs by 1,266.7% in the first quarter. Lindbrook Capital LLC now owns 2,419 shares of the technology company’s stock valued at $221,000 after purchasing an additional 2,242 shares during the last quarter. Allianz Asset Management GmbH grew its position in shares of Amdocs by 66.2% in the first quarter. Allianz Asset Management GmbH now owns 444,104 shares of the technology company’s stock valued at $40,636,000 after purchasing an additional 176,839 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Amdocs in the first quarter worth about $215,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Amdocs during the 1st quarter worth about $8,524,000. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Stock Down 0.8%

Shares of DOX stock opened at $75.39 on Thursday. Amdocs Limited has a one year low of $74.32 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The stock has a fifty day moving average price of $82.45 and a 200 day moving average price of $86.98. The stock has a market cap of $8.51 billion, a P/E ratio of 15.29, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. The company had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The business’s revenue was down 9.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.70 EPS. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. Analysts predict that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Wednesday, December 31st. Amdocs’s payout ratio is presently 41.58%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DOX. Stifel Nicolaus dropped their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Bank of America lowered their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Wolfe Research restated a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $97.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.